Recall conducted overseas Of 2 batches Of Artesunate (Dihydroartemisinin-12-A-Succinate) Powder For Injection 60mg

HSA would like to update healthcare professionals on a recall conducted overseas on 2 batches of artesunate powder for injection (an exempt drug) due to concerns of contamination by E. Coli, E. Fergusonii or Shigella strain, indicating non-sterility of the product and possible contamination at the manufacturing site. The local distributor, Atlantic Pharmaceutical (S) Pte Ltd, has confirmed that these 2 batches have not been supplied locally. As the manufacturing site of this product is still being investigated by the World Health Organisation (WHO), it cannot be ascertained for now if other batches are similarly affected. As a precautionary measure, HSA will be conducting sterility tests on available and incoming batches of Artesunate Powder for Injection 60mg until WHO's investigations has identified the root cause of the problem. Please refer to the letter for more details.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.